Completed
Asthma Biomarker Study
NCT02392481
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 352.2087.44001 Boehringer Ingelheim Investigational Site Leicester, United Kingdom
- 352.2087.44004 Boehringer Ingelheim Investigational Site London, United Kingdom
- 352.2087.44002 Boehringer Ingelheim Investigational Site Manchester, United Kingdom
- 352.2087.44003 Boehringer Ingelheim Investigational Site Southampton, United Kingdom